why choose us

Clinical Trials Search

Showing 11,080 of 132,656 result(s)
Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder

Status: NOT_YET_RECRUITING

Condition: REM Sleep Behavior Disorder

Interventions: Participants will receive once daily (QD) for period of 12 weeks

Date: 2023-06-06

Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial Tumors

Status: Completed

Condition: Intracranial Neoplasm

Interventions: Undergo MRI

Date: 2023-06-06

Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration

Status: NOT_YET_RECRUITING

Condition: Neovascular Age-related Macular Degeneration (nAMD)

Interventions: OCU-10-C-110 for Injection in one of 3 doses

Date: 2023-06-06

Anatomical and Functional Assessment of Ex-vivo Coronary Perfusion

Status: ACTIVE_NOT_RECRUITING

Condition: Cardiac Transplantation

Interventions:

Date: 2023-06-06

Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for High-risk Stage II;III Colorectal Cancer

Status: Completed

Condition: High-risk Stage II Colorectal Cancer

Interventions: ctDNA methylation detection is performed within one month before surgery, within one month after surgery, and every three months after surgery, for a

Date: 2023-06-06

Novel Diagnostic Methods to Identify External Ventricular Drain Associated Infections

Status: Completed

Condition: Ventricular Drain Related Infection

Interventions: Routine sampling of cerebrospinal fluid from the proximal external ventricular drain port.

Date: 2023-06-06

Histopathological Changes in Mycosis Fungoides

Status: Completed

Condition: Mycosis Fungoides

Interventions: biopsy for histopathological examination

Date: 2023-06-06

Insulin Resistance in Atopic Dermatitis Patients

Status: Completed

Condition: Atopic Dermatitis

Interventions:

Date: 2023-06-06

A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of BGB-30813

Status: NOT_YET_RECRUITING

Condition: Advanced Solid Tumors

Interventions: Specified dose administered on specified days

Date: 2023-06-06